Tumor Imaging

  • Helen Ruth Nadel
  • Monica Anne Rossleigh


Clinicians involved in the treatment of children with tumors require diagnostic imaging methods for staging, monitoring effects of treatment, determining optimum timing for definitive surgical procedures or other changes in treatment, and early detection of recurrence. Traditionally, gallium-67 (67Ga) has been the mainstay of pediatric tumor scintigraphy. Thallium-201 (201Tl) and more recently technetium-99m (99mTc)-sestamibi are being used for imaging a wide variety of pediatric primary and metastatic tumors of bone, soft tissue, head and neck, and lymphoma.


Single Photon Emission Compute Tomography Tumor Uptake Single Photon Emission Compute Tomography Imaging Tumor Imaging Single Photon Emission Compute Tomography Study 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Abdel-Dayem HM, Sanchez J, Al-Mohannadi S, Kempf J. Diffuse thallium-201-chloride uptake in hypermetabolic bone marrow following treatment with granulocyte stimulating factor. J Nucl Med 1992;33:2014–2016PubMedGoogle Scholar
  2. 2.
    Aktolun C, Bayhan H, Kir M. Clinical experience with Tc-99m MIBI imaging in patients with malignant tumors: preliminary results and comparison withTl-201. Clin NuclMed 1992;17:171–176CrossRefGoogle Scholar
  3. 3.
    Aktolun C, Demirel D, Kir M, Bayhan H, Maden HA. Technetium-99m-MIBI and thallium-201 uptake in pulmonary actinomycosis. J Nucl Med 1991;32:1429–1431PubMedGoogle Scholar
  4. 4.
    Anderson KC, Leonard RCF, Canellos GP, Skarin AT, Kaplan WD. High dose gallium imaging in lymphoma. Am J Med 1983;75:327–331PubMedCrossRefGoogle Scholar
  5. 5.
    Ando A, Ando I, Katayama M, et al. Biodistributions of 201-thallium in tumor bearing animals and inflammatory lesion induced animals. Eur J Nucl Med 1987;12:567–572PubMedCrossRefGoogle Scholar
  6. 6.
    Ando A, Ando I, Sanada S, Hiraki T, Hisada K. Tumor and liver uptake models of 67Ga-citrate. Eur J Nucl Med 1985;10:262–268PubMedCrossRefGoogle Scholar
  7. 7.
    Ando A, Ando I, Sanada S, et al. Study of the distribution of tumor affinity metal compounds and alkaline metal compounds in the tumor tissues by microautoradiography. Int J Nucl Med Biol 1984;11:195–201PubMedCrossRefGoogle Scholar
  8. 8.
    Atkins HL, Budinger TF, Lebowitz E, et al. Thallium-201 for medical use. Part 3. Human distribution and physical imaging properties. J Nucl Med 1977;18:133–140PubMedGoogle Scholar
  9. 9.
    Balon HR, Fink-Bennett D, Stoffer SS. Technetium-99m-sestamibi uptake by recurrent Hurthle cell carcinoma of the thyroid. J Nucl Med 1992; 33:1393–1395PubMedGoogle Scholar
  10. 10.
    Bearcroft PWP, Wraight EP. Visualization of the axillary vein during 99m-Tc methoxy-isobutyl-isonitrile (MIBI) myocardial imaging. Br J Radiol 1992;65:947–948PubMedCrossRefGoogle Scholar
  11. 11.
    Bekerman C, Pavel DG, Bitran J, Ryo UY, Pinsky S. The effects of inadvertent administration of antineoplastic agents prior to Ga-67 injection: concise communication. J Nucl Med 1984;25:430–435PubMedGoogle Scholar
  12. 12.
    Bekerman C, Port RB, Pang E, Moohr JW, Kranzler JK. Scintigraphic evaluation of childhood malignancies by 67Ga-citrate. Radiology 1978; 127: 719–725PubMedGoogle Scholar
  13. 13.
    Bergström M. Positron emission tomography in tumor diagnosis and treatment follow-up. Acta Oncol 1993;32:183–188PubMedCrossRefGoogle Scholar
  14. 14.
    Berquist T. Magnetic resonance imaging of primary skeletal neoplasms. Radiol Clin North Am 1993; 31:411–424PubMedGoogle Scholar
  15. 15.
    Biersack HJ, Briele B, Hotze AL, et al. The role of nuclear medicine in oncology. Ann Nucl Med 1992;6:131–136PubMedCrossRefGoogle Scholar
  16. 16.
    Bitran JD, Bekerman C, Golomb HM, Simon MA. Scintigraphic evaluation of sarcomata in children and adults by Ga67 citrate. Cancer 1978;42: 1760–1765PubMedCrossRefGoogle Scholar
  17. 17.
    Black KL, Hawkins RA, Kim KT et al. Use of thallium-201 SPECT to quantitate malignancy grade of gliomas. J Neurosurg 1989;71:342–346PubMedCrossRefGoogle Scholar
  18. 18.
    Bradley-Moore PR, Lebowitz E, Greene MW, Atkins HL, Ansari AN. Thallium-201 for medical use. II. Biologic behavior. J Nucl Med 1975; 16: 156–160PubMedGoogle Scholar
  19. 19.
    Brismar T, Collins VP, Kesselberg M. Thallium-201 uptake relates to membrane potential and potassium permeability in human glioma cells. Brain Res 1989;500:30–36PubMedCrossRefGoogle Scholar
  20. 20.
    Britten JS, Blank M. Thallium activation of the (Na+-K+)-activated ATPase of rabbit kidney. BiochimBiophys Acta 1968;159:160–166CrossRefGoogle Scholar
  21. 21.
    Burke GJ, Wei JP, Binet EF. Parathyroid scintigraphy with iodine-123 and Tc-99m sestamibi: imaging findings. AJR 1993;161:1265–1268PubMedCrossRefGoogle Scholar
  22. 22.
    Caluser C, Macapinlac H, Healey J, et al. The relationship between thallium uptake, blood flow, and blood pool activity in bone and soft tissue tumors. Clin Nucl Med 1992:17:565–572PubMedCrossRefGoogle Scholar
  23. 23.
    Campeau RJ, Kronemer KA, Sutherland CM. Concordant uptake of Tc-99m sestamibi and Tl-201 in unsuspected breast tumor. Clin Nucl Med 1992;17:936–937PubMedCrossRefGoogle Scholar
  24. 24.
    Caner B, Kitapçi M, Aras T, et al. Increased accumulation of hexakis (2-methoxyisobutylisonitrile)tech-netium(I) in osteosarcoma and its metastatic lymph nodes. J Nucl Med 1991;32:1977–1978PubMedGoogle Scholar
  25. 25.
    Caner B, Kitapçi M, Unlü M, et al. Technetium-99m MIBI uptake in benign and malignant bone lesions: a comparative study with technetium-99-MDP. J Nucl Med 1992;33:319–324PubMedGoogle Scholar
  26. 26.
    Carvalho PA, Schwartz RB, Alexander E, et al. Detection of recurrent gliomas with quantitative thallium-201/technetium-99m HMPAO single-photon emission computerized tomography. J Neurosurg 1992;77:565–570PubMedCrossRefGoogle Scholar
  27. 27.
    Cavailloles F, Vitaux F, Petiet A, Vitaux J. Thallium uptake in fasted and nonfasted rats. Eur J Nucl Med 1983;8:87–88PubMedCrossRefGoogle Scholar
  28. 28.
    Charkes ND, Vitti RA, Brooks K. Thallium-201 SPECT increases detectability of thyroid cancer metastases. J Nucl Med 1990;31:147–153PubMedGoogle Scholar
  29. 29.
    Chen DCP, Ma GQ, Ansari A, et al. Optimal imaging time for thallium as a tumor agent in patients with lymphoma [abstract]. J Nucl Med 1992;33:844Google Scholar
  30. 30.
    Chen LB. Mitochondrial membrane potential in living cells. Annu Rev Cell Biol 1988;4:155–181PubMedCrossRefGoogle Scholar
  31. 31.
    Chiu ML, Herman LW, Kronauge JF, Piwnica-Worms D. Comparative effects of neutral dipolar compounds and lipophilic anions on technetium 99m-hexakis (2-methoxyisobutyl isonitrile) accumulation in cultured chick ventricular myocytes. Invest Radiol 1992;27:1052–1058PubMedCrossRefGoogle Scholar
  32. 32.
    Chiu ML, Kronauge JF, Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile)technetium(I) in cultured mouse fibroblasts. J Nucl Med 1990;31:1646–1653PubMedGoogle Scholar
  33. 33.
    Cogswell A, Howman-Giles R, Bergin M. Bone and gallium scintigraphy in children with rhabdomyosarcoma: a 10-year review. Med Pediatr Oncol 1994;22:15–21PubMedCrossRefGoogle Scholar
  34. 34.
    Cohen M, Hill CA, Cangir A, Sullivan M. Thymic rebound after treatment of childhood tumors. AJR 1980;135:151–156PubMedCrossRefGoogle Scholar
  35. 35.
    Cox PH, Belfer AJ, van der Pompe WB. Thallium 201 chloride uptake in tumours, a possible complication in heart scintigraphy. Br J Radiol 1976;49:767–768PubMedCrossRefGoogle Scholar
  36. 36.
    Crane P, Laliberté R, Heminway S, Thoolen M, Orlandi C. Effect of mitochondrial viability and metabolism on technetium-99m-sestamibi myocardial retention. Eur J Nucl Med 1993;20:20–25PubMedCrossRefGoogle Scholar
  37. 37.
    Culver CM, Dworkin HJ. Comparison of personnel radiation dosimetry from myocardial perfusion scintigraphy: technetium-99m-sestamibi versus thallium-201. J Nucl Med 1993;34:1210–1213PubMedGoogle Scholar
  38. 38.
    Darcourt J, Chang L, McBride D, et al. Comparison of Tl-201 and Tc-99m-sestamibi SPECT for brain tumor detection [abstract]. Clin Nucl Med 1993; 18:925CrossRefGoogle Scholar
  39. 39.
    Davidson RM, Round ME, Lamki N, et al. Tl-201 chloride scan in multiple endocrine neoplasia type 2A. Clin Nucl Med 1992;17:406–408PubMedCrossRefGoogle Scholar
  40. 40.
    Desai SP, Yuille DL. Visualization of a recurrent carcinoid tumor and an occult distant metastasis by technetium-99m-sestamibi. J Nucl Med 1993;34: 1748–1751PubMedGoogle Scholar
  41. 41.
    DeVito RP, Hamill JJ. Determination of weighting functions for energy-weighted acquisition. J Nucl Med 1991;32:343–349PubMedGoogle Scholar
  42. 42.
    DeVito RP, Hamill JJ, Treffert JD, Stoub EW. Energy-weighted acquisition of scintigraphic images using finite spatial filters. J Nucl Med 1989;30:2029–2035PubMedGoogle Scholar
  43. 43.
    Donahue DM, Leonard JC, Basmadjian GP, et al. Thymic gallium-67 localization in pediatric patients on chemotherapy: concise communication. J Nucl Med 1981;22:1043–1048PubMedGoogle Scholar
  44. 44.
    Donaldson SS, Glatstein E, Rosenberg SA, Kaplan HS. Pediatric Hodgkin’s disease (II): results of therapy. Cancer 1976;37:2436–2447PubMedCrossRefGoogle Scholar
  45. 45.
    Edeling CJ. Ga-67 imaging in pediatric oncology. Clin Nucl Med 1983;8:205–209PubMedCrossRefGoogle Scholar
  46. 46.
    Elgazzar AH, Fernandez-Ulloa M, Silberstein EB. 201T1 as a tumour-localizing agent: current status and future considerations. Nucl Med Commun 1993;14:96–103PubMedCrossRefGoogle Scholar
  47. 47.
    Elgazzar AH, Malki AA, Abdel-Dayem HM, et al. Role of thallium-201 in the diagnosis of solitary bone lesions. Nucl Med Commun 1989; 10:477–485PubMedCrossRefGoogle Scholar
  48. 48.
    Floyd JL, Mann RB, Shaw A. Changes in quantitative SPECT thallium-201 results associated with the use of energy-weighted acquisition. J Nucl Med 1991;32:805–807PubMedGoogle Scholar
  49. 49.
    Földes I, Lévay A, Stotz G. Comparative scanning of thyroid nodules with technetium-99m pertechne-tate and technetium-99m methoxyisobutylisoni-trile. Eur J Nucl Med 1993;20:330–333PubMedCrossRefGoogle Scholar
  50. 50.
    Gal R, Port SC. Arm vein uptake of thallium-201 during exercise: incidence and clinical significance. J Nucl Med 1986;27:1353–1357PubMedGoogle Scholar
  51. 51.
    Ganz WI, Nguyen TQ, Mnaymneh W, et al. Use of early, late and SPECT thallium imaging in evaluating activity of soft tissue and bone tumors [abstract]. J Nucl Med l993;34:33Google Scholar
  52. 52.
    Gehring PJ, Hammond PB. The interrelationship between thallium and potassium in animals. J Pharmacol Exp Ther 1967;155:187–201PubMedGoogle Scholar
  53. 53.
    Gelfand MJ. Meta-iodobenzylguanidine in children. Semin Nucl Med 1993;23:231–242PubMedCrossRefGoogle Scholar
  54. 54.
    Gilday DL, Ash JM, Reilly BJ. Radionuclide skeletal survey for pediatric neoplasms. Radiology 1977;123:399–406PubMedGoogle Scholar
  55. 55.
    Glaspy JA, Hawkins R, Hoh CK, Phelps ME. Use of positron emission tomography in oncology. Oncology 1993;7:41–46PubMedGoogle Scholar
  56. 56.
    Glasser DB, Lane JM, Huvos AG, Marcove RC, Rosen G. Survival, prognosis, and therapeutic response in osteogenic sarcoma: the Memorial Hospital experience. Cancer 1992;69:698–708PubMedCrossRefGoogle Scholar
  57. 57.
    Glover DK, Okada RD. Myocardial technetium 99m sestamibi kinetics after reperfusion in a canine model. Am Heart J 1993;125:657–666PubMedCrossRefGoogle Scholar
  58. 58.
    Graham MM, Eary JF, Winder DP, et al. Sestamibi imaging of sarcoma response to therapy [abstract]. Clin Nucl Med 1993;18:929CrossRefGoogle Scholar
  59. 59.
    Hammersley PAG, Zivanovic MA. Gallium-67 uptake in the regenerating rat liver. J Nucl Med 1976;17:226PubMedGoogle Scholar
  60. 60.
    Hardoff R, Baron E, Sheinfeld M. Early and late lesion-to-non-lesion ratio of thallium-201 chloride uptake in the evaluation of “cold” thyroid nodules. J Nucl Med 1991;32:1873–1876PubMedGoogle Scholar
  61. 61.
    Harris EW, Rakow JI, Weiner M, Agress H Jr. Thallium-201 scintigraphy for assessment of a gal-lium-67-avid mediastinal mass following therapy for Hodgkin’s disease. J Nucl Med 1993; 34:1326–1330PubMedGoogle Scholar
  62. 62.
    Hartman RE, Hayes RL. The binding of gallium by blood serum. J Pharmacol Exp Ther 1969; 168: 193–198PubMedGoogle Scholar
  63. 63.
    Hassan IM, Sahweil A, Constantinides C, et al. Uptake and kinetics of Tc-99m hexakis 2-methoxy isobutyl isonitrile in benign and malignant lesions in the lungs. Clin Nucl Med 1989; 14:333–340PubMedCrossRefGoogle Scholar
  64. 64.
    Hawkins RA, Hoh C, Glaspy J, et al. The role of positron emission tomography in oncology and other whole-body applications. Semin Nucl Med 1992;22:268–284PubMedCrossRefGoogle Scholar
  65. 65.
    Hibi S, Todo S, Imashuku S. Thymic localization of gallium-67 in pediatric patients with lymphoid and nonlymphoid tumours. J Nucl Med 1987;28: 293–297PubMedGoogle Scholar
  66. 66.
    Hisada K, Tonami N, Miyamae T, et al. Clinical evaluation of tumor imaging with 201-T1 chloride. Radiology 1978;129:497–500PubMedGoogle Scholar
  67. 67.
    Hoffer PB. Mechanisms of localization. In Hoffer PB, Bekerman C, Henkin RE (eds): Gallium-67 Imaging. New York: Wiley, 1978Google Scholar
  68. 68.
    Hoffer PB, Schor R, Ashby D, et al. Comparison of Ga-67 citrate images obtained with rectilinear scanner and large-field Anger camera. J Nucl Med 1977;18:538–541PubMedGoogle Scholar
  69. 69.
    Hoffman JM, Hanson MW, Coleman RE. Clinical positron emission tomography imaging. Radiol Clin NorthAm 1993;31:935–959Google Scholar
  70. 70.
    Holman BL, Zimmerman RE, Johnson KA, et al. Computer-assisted superimposition of magnetic resonance and high-resolution technetium-99m-HMPAO and thallium-201 SPECT images of the brain. J Nucl Med 1991;32:1478–1484PubMedGoogle Scholar
  71. 71.
    Howman-Giles R, Stevens M, Bergin M. Role of gallium-67 in management of paediatric solid tumors. AustPaediatri J 1982;18:120–125Google Scholar
  72. 72.
    Howman-Giles R, Uren R, White G, Shaw P. Tl-201 scintigraphy in paediatric solid tumors [abstract]. J Nucl Med 1993;34:52Google Scholar
  73. 73.
    Iosilevsky G, Front D, Bettman L, Hardoff R, Ben-Arieh Y. Uptake of gallium-67 citrate and [2-3H]deoxyglucose in the tumor model, following chemotherapy and radiotherapy. J Nucl Med 1985;26:278–282PubMedGoogle Scholar
  74. 74.
    Iosilevsky G, Israel O, Frenkel A, et al. A practical SPECT technique for quantitation of drug delivery to human tumors and organ absorbed radiation dose. Semin Nucl Med 1989;19:33–46PubMedCrossRefGoogle Scholar
  75. 75.
    Israel O, Front D. Benign mediastinal and parahilar uptake of gallium-67 in treated lymphoma: do we have all the answers? J Nucl Med 1993; 34:1330–1332PubMedGoogle Scholar
  76. 76.
    Ito Y, Muranaka A, Harada T, et al. Experimental study on tumor affinity of 201T1 chloride. Eur J Nucl Med 1978;3:81–86PubMedCrossRefGoogle Scholar
  77. 77.
    Kao CH, Wang SJ, Lin WY, et al. Differentiation of single solid lesions in the lungs by means of single-photon emission tomography with technetium-99m methoxyisobutylisonitrile. Eur J Nucl Med 1993; 20:249–254PubMedGoogle Scholar
  78. 78.
    Kaplan WD. Residual mass and negative gallium scintigraphy in treated lymphoma: when is the gallium scan really negative? J Nucl Med 1990; 31:369–371PubMedGoogle Scholar
  79. 79.
    Kaplan WD, Southee AE, Annese ML, Jochhelson MS, Nadler LM. Evaluating low and intermediate grade non-Hodgkin’s lymphoma with gallium-67 (Ga) and thallium-201 (Tl) imaging [abstract]. J Nucl Med 1990;31:793Google Scholar
  80. 80.
    Kaplan WD, Takvorian T, Morris JH, et al. Thallium-201 brain tumor imaging: a comparative study with pathologic correlation. J Nucl Med 1987;28:47–52PubMedGoogle Scholar
  81. 81.
    Kaufman JH, Cedermark BJ, Parthasarathy KL, Didolkar MS, Bakshi SP. The value of Ga-67 scintigraphy in soft-tissue sarcoma and chondrosarcoma. Radiology 1977;123:131–134PubMedGoogle Scholar
  82. 82.
    Kim KT, Black KL, Marciano D, et al. Thallium-201 SPECT imaging of brain tumors: methods and results. J Nucl Med 1990;31:965–969PubMedGoogle Scholar
  83. 83.
    Kobayashi H, Sakahara H, Hosono M, et al. Soft-tissue tumors: diagnosis with Tc-99m (V) dimercapto-succinic acid scintigraphy. Radiology 1994; 190:277–280PubMedGoogle Scholar
  84. 84.
    Kohno H, Iizuka Y, Suzuki T, Ohkubo Y, Kubodera A. Developmental changes in tissue distribution of gallium-67 citrate. J Nucl Med 1985;26:761–764PubMedGoogle Scholar
  85. 85.
    Kosuda S, Aoki S, Suzuki K, Nakamura O, Shidara N. Reevaluation of quantitative thallium-201 brain SPECT for brain tumor [abstract]. J Nucl Med 1992;33:844Google Scholar
  86. 86.
    Kowalsky RJ, Perry JR. Radiopharmaceuticals in Nuclear Medicine Practice. Norwalk, CT: Appleton & Lange, 1987Google Scholar
  87. 87.
    Krasnow AZ, Collier BD, Isitman AT, Hellman RS, Peck DC. The clinical significance of unusual sites of thallium-201 uptake. Semin Nucl Med 1988;18:350–358PubMedCrossRefGoogle Scholar
  88. 88.
    Krishna L, Slizofski WJ, Katsetos CD, et al. Abnormal intracerebral thallium localization in a bacterial brain abscess. J Nucl Med 1992; 33:2017–2019PubMedGoogle Scholar
  89. 89.
    Laliberté F, Barry T, Gagnon S, Lambert R. Tumor imaging with Tl-201 or Tc-99m MIBI in children: patient preparation and technical aspects [abstract]. J Nucl Med Technol 1993;21:117Google Scholar
  90. 90.
    Lawrence JA, Babyn PS, Chan HS, et al. Extremity osteosarcoma in childhood: prognostic value of radiologic imaging. Radiology 1993; 189:43–47PubMedGoogle Scholar
  91. 91.
    Lebouthillier G, Morais J, Picard M, et al. Tc-99m sestamibi and other agents in the detection of metastatic medullary carcinoma of the thyroid. Clin Nucl Med 1993;18:657–661PubMedCrossRefGoogle Scholar
  92. 92.
    Lebowitz E, Greene MW, Fairchild R, et al. Thallium-201 for medical use. I. J Nucl Med 1975;16:151–155Google Scholar
  93. 93.
    Lee VW. Unsuspected malignant pheochromocy-toma: appearance on thallium and gallium scans. AJR1993;161:1333Google Scholar
  94. 94.
    Lee VW, Chen H, Panageas E, O’Keane JC, Liebman HA. Subcutaneous Kaposi’s sarcoma: thallium scan demonstration. Clin Nucl Med 1990;15:569–571PubMedCrossRefGoogle Scholar
  95. 95.
    Lee VW, Fuller JD, O’Brien MJ, et al. Pulmonary Kaposi sarcoma in patients with AIDS: scintigraphic diagnosis with sequential thallium and gallium scanning. Radiology 1991; 180:409–412PubMedGoogle Scholar
  96. 96.
    Lee VW, Sax EJ, McAneny DB, et al. A complementary role for thallium-201 scintigraphy with mammography in the diagnosis of breast cancer. J Nucl Med 1993;34:2095–2100PubMedGoogle Scholar
  97. 97.
    Luker GD, Siegel MJ. Mediastinal Hodgkin disease in children: response to therapy. Radiology 1993; 189:737–740PubMedGoogle Scholar
  98. 98.
    Macapinlac H, Scott A, Caluser C, et al. Comparison of Tl-201 and Tc-99m-2-methoxy isobutyl isonitrile (MIBI) with MRI in the evaluation of recurrent brain tumors [abstract]. J Nucl Med 1992;33:867Google Scholar
  99. 99.
    Magid D. Two-dimensional and three-dimensional computed tomographic imaging in musculoskeletal tumors. Radiol Clin North Am 1993;31:425–447PubMedGoogle Scholar
  100. 100.
    Majd M, Packer R, Vezina G, Melis K, Chadduck W Thallium-201 brain SPECT in childhood brain tumors [abstract]. J Nucl Med 1993;34:52Google Scholar
  101. 101.
    Maublant JC, Zhang Z, Rapp M, et al. In vitro uptake of technetium-99m-teboroxime in carcinoma cell lines and normal cells: comparison with technetium-99m-sestamibi and thallium-201. J Nucl Med 1993;34:1949–1952PubMedGoogle Scholar
  102. 102.
    McLaughlin AF, Magee MA, Greenough R, et al. Current role of gallium scanning in the management of lymphoma. Eur J Nucl Med 1990;16:755–771PubMedCrossRefGoogle Scholar
  103. 103.
    Mountz JM, Raymond PA, McKeever PE, et al. Specific localization of thallium 201 in human high-grade astrocytoma by microautoradiography. Cancer Res 1989;49:4053–4056PubMedGoogle Scholar
  104. 104.
    Mountz JM, Rosenfeld SS, Li Y. Utility of Tl-201 and Tc-99m sestamibi SPECT for early determination of malignant brain tumor chemotherapy efficacy [abstract]. J Nucl Med 1993;34:206Google Scholar
  105. 105.
    Mousa SA, Cooney JM, Stevens S. Kinetics of technetium-99m-sestamibi and thallium-201 in a transient ischemic myocardium animal model: insight into the ‘redistribution’ phenomenon. Cardiology 1992;81:157–163PubMedCrossRefGoogle Scholar
  106. 106.
    Mousa SA, Williams S J, Sands H. Characterization of in vivo chemistry of cations in the heart. J Nucl Med 1987;28:1351–1357PubMedGoogle Scholar
  107. 107.
    Muranaka A. Accumulation of radioisotopes with tumor affinity. II. Comparison of the tumor accumulation of Ga-67 citrate and thallium-201 chloride in vitro. Acta Med Okayama 1981;35:85–101PubMedGoogle Scholar
  108. 108.
    Mut F, Bianco A, Nunez M, De Palma G, Touya E. Tc-99m isonitrile uptake in a brain metastatic lesion: comparison with Tc-99m DTPA using planar and SPECT imaging. Clin Nucl Med 1993;18: 143–146PubMedCrossRefGoogle Scholar
  109. 109.
    Nadel HR. Thallium-201 for oncological imaging in children. Semin Nucl Med 1993;23:243–254PubMedCrossRefGoogle Scholar
  110. 110.
    Nadel HR, Frankel M, Chan KW, Stringer DA. Evaluation of Tl-201 scintigraphy in pediatric extremity osteogenic sarcoma [abstract]. Radiology 1992;185:107Google Scholar
  111. 111.
    Nadel HR, Poskitt KJ, Flodmark CO. Thallium beyond the heart: a pediatric experience [abstract]. Radiology 1989;173:151Google Scholar
  112. 112.
    Nadel HR, Poskitt KJ, Flodmark CO. Thallium scintigraphy in childhood neoplasms [abstract]. J Nucl Med 1990;31:939Google Scholar
  113. 113.
    Nakano S, Hasegawa Y, Kuriyama K, Kajita A, Ishigami S. Visualization of jugular vein on a thallium-201 scan for thyroid cancer. Clin Nucl Med 1989;14:449–450PubMedCrossRefGoogle Scholar
  114. 114.
    Nishizawa K, Okunieff P, Elmaleh D, et al. Blood flow of human soft tissue sarcomas measured by thallium-201 scanning: prediction of tumor response to radiation. Int J Radiat Oncol Biol Phys 1991;20:593–597PubMedCrossRefGoogle Scholar
  115. 115.
    O’Doherty MJ, Kettle AG, Wells P, Collins REC, Coakley AJ. Parathyroid imaging with technetium-99m-sestamibi: preoperative localization and tissue uptake studies. JNuclMed 1992;33:313–318Google Scholar
  116. 116.
    Ogawa T, Kanno I, Hatazawa J, et al. Methionine PET for follow-up of radiation therapy of primary lymphoma of the brain. Radiographics 1994; 14:101–110PubMedGoogle Scholar
  117. 117.
    Oriuchi N, Tamura M, Shibazaki T, et al. Clinical evaluation of thallium-201 SPECT in supratentorial gliomas: relationship to histologic grade, prognosis and proliferative activities. J Nucl Med 1993; 34:2085–2089PubMedGoogle Scholar
  118. 118.
    Osmanagaoglu K, Schelstraete K, Lippens M, Obrie E, De Feyter I. Visualization of a parathyroid adenoma with Tc-99m MIBI in a case with iodine saturation and impaired thallium uptake. Clin Nucl Med 1993;18:214–216PubMedCrossRefGoogle Scholar
  119. 119.
    O’Tuama LA, Janicek MJ, Barnes PD, et al. 201Tl/99mTc-HMPAO SPECT imaging of treated childhood brain tumors. Pediatr Neurol 1991; 7:249–257PubMedCrossRefGoogle Scholar
  120. 120.
    O’Tuama LA, Packard AB, Treves ST. SPECT imaging of pediatric brain tumor with hexakis (methoxyisobutylisonitrile) technetium (I). J Nucl Med 1990;31:2040–2041PubMedGoogle Scholar
  121. 121.
    O’Tuama LA, Treves ST, Larar JN, et al. Thallium-201 versus technetium-99m-MIBI SPECT in evaluation of childhood brain tumors: a within-subject comparison. J Nucl Med 1993;34:1045–1051PubMedGoogle Scholar
  122. 122.
    Parker JA. Quantitative SPECT: basic theoretical considerations. Semin Nucl Med 1989;19:3–12PubMedCrossRefGoogle Scholar
  123. 123.
    Picci P, Rougraff BT, Bacci G, et al. Prognostic significance of histopathologic response to chemotherapy in nonmetastic Ewing’s sarcoma of the extremities. J Clin Oncol 1993;11:1763–1769PubMedGoogle Scholar
  124. 124.
    Piwnica-Worms D, Chiu ML, Budding M, et al. Functional imaging of multidrug-resistant P-glyco-protein with an organotechnetium complex. Cancer Res 1993;53:977–984PubMedGoogle Scholar
  125. 125.
    Piwnica-Worms D, Holman BL. Noncardiac applications of hexakis-(alkylisonitrile) technetium-99m complexes. J Nucl Med 1990;31:1166–1167PubMedGoogle Scholar
  126. 126.
    Piwnica-Worms D, Kronauge JF, Chiu ML. Enhancement by tetraphenylborate of technetium-99m-MIBI uptake kinetics and accumulation in cultured chick myocardial cells. J Nucl Med 1991; 32:1992–1999PubMedGoogle Scholar
  127. 127.
    Podoloff DA, Kim EE, Haynie TP. SPECT in the evaluation of cancer patients: not quo vadis; rather, ibi fere summus. Radiology 1992;183:305–317PubMedGoogle Scholar
  128. 128.
    Pruim J, Nieweg OE, Paans AMJ, et al. Efficacy assessment of regional chemotherapy of soft tissue sarcomas by FDG-PET [abstract]. J Nucl Med 1993:34:225Google Scholar
  129. 129.
    Ramanna L, Waxman A, Binney G, et al. Thallium-201 scintigraphy in bone sarcoma: comparison with gallium-67 and technetium-MDP in the evaluation of chemotherapeutic response. J Nucl Med 1990; 31:567–572PubMedGoogle Scholar
  130. 130.
    Ramanna L, Waxman AD, Rosen G. Evaluation of Tl-201 (Tl) uptake pattern in bone lesions: differentiation of benign from malignant processes [abstract]. J Nucl Med 1992;33:869Google Scholar
  131. 131.
    Ramanna L, Waxman AD, Weiss A, Rosen G. Thallium-201 (Tl-201) scan patterns in bone and soft tissue sarcoma [abstract]. J Nucl Med 1992; 33:843Google Scholar
  132. 132.
    Rao MG, Bone imaging with energy-weighted acquisition. J Nucl Med 1993;34:997–999PubMedGoogle Scholar
  133. 133.
    Rosen G, Loren GJ, Brien EW, et al. Serial thallium-201 scintigraphy in osteosarcoma: correlation with tumor necrosis after preoperative chemotherapy. Clin Orthop 1993;293:302–306PubMedGoogle Scholar
  134. 134.
    Rossleigh MA, Murray IPC, Mackey DWJ, Bargwanna KA, Nayanar VV. Pediatric solid tumors: evaluation by gallium-67 SPECT studies. J Nucl Med 1990;31:168–172PubMedGoogle Scholar
  135. 135.
    Rubertone JA, Woo DV, Emrich JG, Brady LW Brain uptake of thallium-201 from the cerebrospinal fluid compartment. J Nucl Med 1993;34:99–103PubMedGoogle Scholar
  136. 136.
    Salvatore M, Carratù L, Porta E. Thallium-201 as a positive indicator for lung neoplasms: preliminary experiments. Radiology 1976;121:487–488PubMedGoogle Scholar
  137. 137.
    Schwartz RB, Carvalho PA, Alexander E, et al. Radiation necrosis vs high-grade recurrent glioma: differentiation by using dual-isotope SPECT with 201T1 and 99mTc -HMPAO. AJNR 1991;12: 1187–1192PubMedGoogle Scholar
  138. 138.
    Scott AM, Kostakoglu L, O’Brien JP, et al. Comparison of technetium-99m-MIBI and thallium-201-chloride uptake in primary thyroid lymphoma. J Nucl Med 1992;33:1396–1398PubMedGoogle Scholar
  139. 139.
    Scott AM, Larson SM. Tumor imaging and therapy. Radiol Clin North Am 1993;31:859–879PubMedGoogle Scholar
  140. 140.
    Sehweil A, McKillop JH, Ziada G, et al. The optimum time for tumour imaging with thallium-201. Eur J Nucl Med 1988;13:527–529PubMedCrossRefGoogle Scholar
  141. 141.
    Sehweil AM, McKillop JH, Milroy R, et al. Mechanism of 201T1 uptake in tumours. Eur J Nucl Med 1989;15:376–379PubMedCrossRefGoogle Scholar
  142. 142.
    Sessler MJ, Geck P, Maul FD, Hör G, Munz DL. New aspects of cellular thallium uptake: Tl+-Na+-2C1- cotransport is the central mechanism of ion uptake. Nucl Med 1986;23:24–27Google Scholar
  143. 143.
    Shih WJ, Kadzielawa K, Lee C, Moody EB, Ryo UY. Tc-99m sestamibi uptake by cerebellar metastasis from bronchogenic carcinoma. Clin Nucl Med 1993;18:887–890PubMedCrossRefGoogle Scholar
  144. 144.
    Simon MA, Kirchner PT. Scintigraphic evaluation of primary bone tumors: comparison of technetium-99m phosphonate and gallium citrate imaging. J Bone Joint Surg [Am] 1980;62:758–764Google Scholar
  145. 145.
    Sostman HD, Prescott DM, Dewhirst MW, et al. MR imaging and spectroscopy for prognostic evaluation in soft-tissue sarcomas. Radiology 1994; 190: 269–275PubMedGoogle Scholar
  146. 146.
    Southee AE, Kaplan WD, Jochelson MS, et al. Gallium imaging in metastatic and recurrent soft-tissue sarcoma. J Nucl Med 1992;33:1594–1599PubMedGoogle Scholar
  147. 147.
    Stobbe DE, Berman S, Sanford I, Milne N, Lyons KP. Localization of Kaposi’s sarcoma by Tc-99m sestamibi compared to Tl-201: a pilot study [abstract]. Clin Nucl Med 1993; 18:925CrossRefGoogle Scholar
  148. 148.
    Stull MA, Kransdorf MJ, Devaney KO. Langerhans cell histiocytosis of bone. Radiographics 1992; 12:801–823PubMedGoogle Scholar
  149. 149.
    Sty JR, Kun LE, Starshak RJ. Pediatric applications in nuclear oncology. Semin Nucl Med 1985; 15: 171–200PubMedCrossRefGoogle Scholar
  150. 150.
    Suga K, Fujita T, Nakada T, et al. Preliminary Tl-201 SPECT for assessment of treatment efficacy in three patients with pancreatic cancer. Clin Nucl Med 1993;18:771–775PubMedCrossRefGoogle Scholar
  151. 151.
    Suga K, Sadanaga Y, Nishigauchi K, Uschisako H, Nakanishi T. Lobar primary pulmonary lymphoma: iodine-123-iodoamphetamine and thallium-201 -chloride scintigraphic findings. J Nucl Med 1993; 34:1980–1983PubMedGoogle Scholar
  152. 152.
    Taillefer R, Boucher Y, Potvin C, Lambert R. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study). J Nucl Med 1992;33:1801–1807PubMedGoogle Scholar
  153. 153.
    Takechi T, Mochizuki T, Murase K, et al. Dual energy acquisition for liver tumor imaging by thal-lium-201 and technetium-99m phytate with high resolution three head SPECT [abstract]. J Nucl Med 1992;33:976Google Scholar
  154. 154.
    Takeda S, Uchida T, Matsuzawa T. A comparative study on lysosomal accumulation of gallium-67 and indium-111 in Morris hepatoma 7316A. J Nucl Med 1977;18:835–839PubMedGoogle Scholar
  155. 155.
    Tanasescu DE, Hurvitz C, Waxman AD, Ramanna L, Rosen G. Thallium scintigraphy in pediatric oncology [abstract]. Radiology 1989;173:182Google Scholar
  156. 156.
    Thrall J, Freitas J, Gross M, et al. Non-cardiac organ perfusion imaging with thallium-201 [abstract]. J Nucl Med 1978;19:708–709Google Scholar
  157. 157.
    Togawa T, Yui N, Kinoshita F, et al. Diagnosis of pancreatic cancer using 201Tl-chloride and a three-head rotating gamma camera SPECT system. Kaku Igaku [Japanese Journal of Nuclear Medicine] 1991;28:1475–1481Google Scholar
  158. 158.
    Tonami N. Thallium-201 SPECT in the evaluation of gliomas. J Nucl Med 1993;34:2089–2090PubMedGoogle Scholar
  159. 159.
    Tonami N, Hisada K. Clinical experience of tumor imaging with thallium-201 chloride. Clin Nucl Med 1977;2:75–81CrossRefGoogle Scholar
  160. 160.
    Tonami N, Matsuda H, Ooba H, et al. Thallium-201 accumulation in cerebral candidiasis: unexpected finding on SPECT. Clin Nucl Med 1990;15: 397–400PubMedCrossRefGoogle Scholar
  161. 161.
    Tonami N, Shuke N, Yokoyama K, et al. Thallium-201 single photon emission computed tomography in the evaluation of suspected lung cancer. J Nucl Med 1989;30:997–1004Google Scholar
  162. 162.
    Tsan MF, Scheffel U. Mechanism of gallium-67 accumulation in tumors. J Nucl Med 1986; 27:1215–1219PubMedGoogle Scholar
  163. 163.
    Tumeh SS, Rosenthal DS, Kaplan WD, English RJ, Holman BL. Lymphoma: evaluation with Ga-67 SPECT. Radiology 1987;164:111–114PubMedGoogle Scholar
  164. 164.
    Turner DA, Pinsky SM, Gottschalk A, et al. The use of 67-Ga scanning in the staging of Hodgkin’s disease. Radiology 1972;104:97–101PubMedGoogle Scholar
  165. 165.
    Vallabhajosula SR, Harwig JF, Siemsen JK, Wolf W. Radiogallium localization in tumors: blood binding and transport and the role of transferrin. J Nucl Med 1980;21:650–656PubMedGoogle Scholar
  166. 166.
    Van Der Wall H, Murray IPC, Huckstep RL, Philips RL. The role of thallium scintigraphy in excluding malignancy in bone. Clin Nucl Med 1993;18: 551–557PubMedCrossRefGoogle Scholar
  167. 167.
    Vanarthos WJ, Ganz WI, Vanarthos JC, Serafini AN, Tehranzadeh J. Diagnostic uses of nuclear medicine in AIDS. Radiographics 1992;12:731–749PubMedGoogle Scholar
  168. 168.
    Wackers FJT, Berman DS, Maddahi J, et al. Technetium-99m hexakis 2-methoxyisobutyl isoni-trile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med 1989; 30:301–311PubMedGoogle Scholar
  169. 169.
    Waxman A, Ashok G, Kooba A, et al. The use of Tc-99m-methoxy isobutyl isonitrile (MIBI) in evaluation of patients with primary carcinoma of the breast: comparison with Tl-201 (Tl) [abstract]. J Nucl Med 1993;34:139Google Scholar
  170. 170.
    Waxman AD. Thallium in nuclear oncology. In: Freeman LM (ed): Nuclear Medicine Annual. New York: Raven Press, 1991Google Scholar
  171. 171.
    Waxman AD, Ashok G, Khan S, et al. The use of methoxy isobutyl isonitrile (MIBI) in evaluation of patients with primary carcinoma of the breast [abstract]. Clin Nucl Med 1993;18:925CrossRefGoogle Scholar
  172. 172.
    Waxman AD, Ramanna L, Memsic LD, et al. Thallium scintigraphy in the evaluation of mass abnormalities of the breast. J Nucl Med 1993; 34:18–23PubMedGoogle Scholar
  173. 173.
    Waxman AD, Ramanna L, Said J. Thallium scintigraphy in lymphoma: relationship to gallium-67 [abstract]. J Nucl Med 1989;30:915Google Scholar
  174. 174.
    Wei JP, Burke GJ, Mansberger AR Jr. Prospective evaluation of the efficacy of technetium 99m sestamibi and iodine 123 radionuclide imaging of abnormal parathyroid glands. Surgery 1992; 112:1111–1117PubMedGoogle Scholar
  175. 175.
    Winchell HS. Mechanisms for localization of radiopharmaceuticals in neoplasms. Semin Nucl Med 1976;6:371–378PubMedCrossRefGoogle Scholar
  176. 176.
    Yang SL, Alderson PO, Kaizer HA, Wagner HN Jr. Serial Ga-67 citrate imaging in children with neoplastic disease: concise communication. J Nucl Med 1979;20:210–214Google Scholar
  177. 177.
    Yeh SDJ, Rosen G, Caparros B, Benua RS. Semiquantitative gallium scintigraphy in patients with osteogenic sarcoma. Clin Nucl Med 1984; 9:175–183PubMedCrossRefGoogle Scholar
  178. 178.
    Zhang JJ, Park CH, Kim SM, Ayyangar KM, Haghbin M. Dual isotope SPECT in the evaluation of recurrent brain tumor. Clin Nucl Med 1992; 17:663–664PubMedCrossRefGoogle Scholar
  179. 179.
    Zolty IS, Murthy S, Delaney ML, Machac J. Technical considerations of thallium-201 whole body scanning [abstract]. J Nucl Med Technol 1993;21:112Google Scholar

Copyright information

© Springer Science+Business Media New York 1995

Authors and Affiliations

  • Helen Ruth Nadel
  • Monica Anne Rossleigh

There are no affiliations available

Personalised recommendations